VRTX vs. BX
Compare and contrast key facts about Vertex Pharmaceuticals Incorporated (VRTX) and The Blackstone Group Inc. (BX).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: VRTX or BX.
Correlation
The correlation between VRTX and BX is 0.45, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.
Performance
VRTX vs. BX - Performance Comparison
Loading data...
Key characteristics
VRTX:
-0.03
BX:
0.39
VRTX:
0.23
BX:
1.08
VRTX:
1.03
BX:
1.14
VRTX:
0.04
BX:
0.60
VRTX:
0.11
BX:
1.51
VRTX:
9.06%
BX:
15.51%
VRTX:
28.64%
BX:
38.68%
VRTX:
-91.77%
BX:
-87.65%
VRTX:
-15.94%
BX:
-25.12%
Fundamentals
VRTX:
$108.15B
BX:
$180.07B
VRTX:
-$3.80
BX:
$3.29
VRTX:
2.57
BX:
2.18
VRTX:
9.74
BX:
14.55
VRTX:
6.72
BX:
14.23
VRTX:
$11.09B
BX:
$11.95B
VRTX:
$9.54B
BX:
$11.95B
VRTX:
-$228.00M
BX:
$6.03B
Returns By Period
In the year-to-date period, VRTX achieves a 7.87% return, which is significantly higher than BX's -13.56% return. Over the past 10 years, VRTX has underperformed BX with an annualized return of 13.09%, while BX has yielded a comparatively higher 18.66% annualized return.
VRTX
7.87%
-13.21%
-10.24%
-0.71%
8.54%
13.09%
BX
-13.56%
10.67%
-17.75%
14.75%
27.98%
18.66%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
VRTX vs. BX — Risk-Adjusted Performance Rank
VRTX
BX
VRTX vs. BX - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Vertex Pharmaceuticals Incorporated (VRTX) and The Blackstone Group Inc. (BX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Loading data...
Dividends
VRTX vs. BX - Dividend Comparison
VRTX has not paid dividends to shareholders, while BX's dividend yield for the trailing twelve months is around 2.76%.
| TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
VRTX Vertex Pharmaceuticals Incorporated | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
BX The Blackstone Group Inc. | 2.76% | 2.00% | 2.54% | 6.66% | 2.76% | 2.95% | 3.43% | 8.12% | 7.25% | 8.44% | 9.76% | 5.57% |
Drawdowns
VRTX vs. BX - Drawdown Comparison
The maximum VRTX drawdown since its inception was -91.77%, roughly equal to the maximum BX drawdown of -87.65%. Use the drawdown chart below to compare losses from any high point for VRTX and BX. For additional features, visit the drawdowns tool.
Loading data...
Volatility
VRTX vs. BX - Volatility Comparison
The current volatility for Vertex Pharmaceuticals Incorporated (VRTX) is 13.64%, while The Blackstone Group Inc. (BX) has a volatility of 14.37%. This indicates that VRTX experiences smaller price fluctuations and is considered to be less risky than BX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading data...
Financials
VRTX vs. BX - Financials Comparison
This section allows you to compare key financial metrics between Vertex Pharmaceuticals Incorporated and The Blackstone Group Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
VRTX vs. BX - Profitability Comparison
VRTX - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Vertex Pharmaceuticals Incorporated reported a gross profit of 2.41B and revenue of 2.77B. Therefore, the gross margin over that period was 86.9%.
BX - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, The Blackstone Group Inc. reported a gross profit of 2.83B and revenue of 2.83B. Therefore, the gross margin over that period was 100.0%.
VRTX - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Vertex Pharmaceuticals Incorporated reported an operating income of 630.10M and revenue of 2.77B, resulting in an operating margin of 22.8%.
BX - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, The Blackstone Group Inc. reported an operating income of 1.45B and revenue of 2.83B, resulting in an operating margin of 51.4%.
VRTX - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Vertex Pharmaceuticals Incorporated reported a net income of 646.30M and revenue of 2.77B, resulting in a net margin of 23.3%.
BX - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, The Blackstone Group Inc. reported a net income of 614.85M and revenue of 2.83B, resulting in a net margin of 21.8%.